|
Evaxion A/S
(NASDAQ: EVAX)
|
9:00 PM UTC, 12/12/25 | |||
|---|---|---|---|---|
| Last: $6.21 | Change: -0.24 | %Change: -3.72% | Volume: 70,895 | |
11:04 AM EST, 02/11/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were higher late Tuesday morning, rising 0.59% to 1,393.03 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by Spanish lender Banco Santander (SAN) and biotech company Evaxion Biotech (EVAX), which rose 3.8% and 2.5% respectively. They were followed by software firm SAP (SAP) and Spanish financial services company Banco Bilbao Vizcaya Argentaria (BBVA), which were up 2% and 1.9% respectively.
The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and accommodations booking company trivago (TRVG), which dropped 9.6% and 8.5% respectively. They were followed by biopharmaceutical companies Cellectis (CLLS) and argenx (ARGX), which were down 2.5% and 2% respectively.
From the UK and Ireland, the gainers were led by oil and gas company Shell (SHEL) and British bank Barclays (BCS), which increased 1.7% and 1.5% respectively. They were followed by medical device maker Smith & Nephew (SNN) and British financial services company HSBC (HSBC), which were up 1.4% and 1.1% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and pharmaceutical company Silence Therapeutics (SLN), which fell 16% and 11% respectively. They were followed by biopharmaceutical companies Akari Therapeutics (AKTX) and Bicycle Therapeutics (BCYC), which lost 7.4% and 3.5% respectively.
http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.